
Startup
InSphero
Develops 3D tissue and Akura Flow organ-on-chip platforms for preclinical research.
Nobody has vouched for InSphero yet
The first person to vouch is the scout. Everyone after adds their name and their reason.
Scouted by
Nobody yet
The first person to vouch for InSphero is its scout, and that stays on the record.
Vouched by
Open. Vouches appear here in the order they were made.
Believe in InSphero? Be its scout.
One reason, in your own words. It takes about two minutes.
Vouch for InSpheroWhat vouching gets you
The founders are told
You may be invited in
Who believed, and when
Each vouch on one line, from the first one to today, and how those people know the startup.
No vouches yet. The line starts on the day of the first one.
Why people vouch
Each person says how they know the startup and why they believe in it.
No reasons yet
Reasons appear here in the words of the people who gave them, scout first.
From the founders
This page has not been claimed
When the founders of InSphero claim it with a work email, their names and their reply to the people who vouched appear here. Claiming is coming soon.
More startups in Organ-on-Chip
StartupDevelops mechanically active organ-on-chip systems, including breathing lung models.
StartupDevelops mechanically stimulated beating organ-on-chip models.
StartupDevelops PhysioMimix single- and multi-organ microphysiological systems.
StartupDevelops Organ-Chip systems and human-relevant tissue models for drug discovery and development.
StartupProvides Human-on-a-Chip systems and contract research for drug safety and efficacy.
StartupDevelops the OrganoPlate organ-on-chip platform and human tissue models for drug development.
What you can do with InSphero
Two of these work today. The rest are on the way.
Claim this page
Follow InSphero
Send it to an investor
Ask for an introduction
Is this page right?How the research works